Literature DB >> 16371740

Prevention of biliary lesions that may occur during radiofrequency ablation of the liver: study on the pig.

Frédéric Marchal1, Dominique Elias, Philippe Rauch, Rasa Zarnegar, Agnès Leroux, Joseph Stines, Jean-Luc Verhaeghe, François Guillemin, Jean Pierre Carteaux, Jean Pierre Villemot.   

Abstract

OBJECTIVE: To prevent bile duct injury by using a cold 5% glucose isotonic solution cooling in the bile ducts when radiofrequency (RF) is performed in a porcine model. SUMMARY BACKGROUND DATA: Complications that may arise during liver RF ablation include biliary stenosis and abscesses.
METHODS: The RITA 1500 generator was used for the experiments. Two lesions were performed in the left liver. The pigs were killed 1 or 3 weeks after the procedure. An ex vivo cholangiogram was obtained by direct injection into the main bile duct. Samples of RF lesions, of liver parenchyma near and at a distance from the RF lesions, underwent pathologic studies. Two groups of 20 pigs each were treated: one without perfusion of the bile ducts and the other with perfusion of cold 5% glucose isotonic solution into the bile ducts. The Pringle maneuver was used in 50% of the RF procedures. Radiologic lesions were classified as biliary stenosis, complete interruption of the bile duct, or extravasation of the radiologic contrast liquid.
RESULTS: Histologic lesions of the bile ducts were observed near the ablated RF lesion site and at a distance from the RF lesions when a Pringle maneuver was performed. Radiologic and histologic lesions of the bile ducts were significantly reduced (P < 0.0001) when the bile ducts were cooled.
CONCLUSIONS: Cooling of the bile ducts with a cold 5% glucose isotonic solution significantly protects the intrahepatic bile ducts from damages caused by the heat generated by RF when performed close to the bile ducts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16371740      PMCID: PMC1449965          DOI: 10.1097/01.sla.0000193831.39362.07

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  33 in total

1.  Intraductal cooling of the main bile ducts during intraoperative radiofrequency ablation.

Authors:  E Dominique; A El Otmany; A Goharin; D Attalah; T de Baere
Journal:  J Surg Oncol       Date:  2001-04       Impact factor: 3.454

2.  Radio-frequency thermal ablation with NaCl solution injection: effect of electrical conductivity on tissue heating and coagulation-phantom and porcine liver study.

Authors:  S N Goldberg; M Ahmed; G S Gazelle; J B Kruskal; J C Huertas; E F Halpern; B S Oliver; R E Lenkinski
Journal:  Radiology       Date:  2001-04       Impact factor: 11.105

3.  Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year.

Authors:  T de Baere; D Elias; C Dromain; M G Din; V Kuoch; M Ducreux; V Boige; N Lassau; V Marteau; P Lasser; A Roche
Journal:  AJR Am J Roentgenol       Date:  2000-12       Impact factor: 3.959

Review 4.  Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough.

Authors:  G D Dodd; M C Soulen; R A Kane; T Livraghi; W R Lees; Y Yamashita; A R Gillams; O I Karahan; H Rhim
Journal:  Radiographics       Date:  2000 Jan-Feb       Impact factor: 5.333

Review 5.  Radiofrequency ablation of malignant liver tumors.

Authors:  S A Curley
Journal:  Oncologist       Date:  2001

6.  Radiofrequency liver ablation: experimental comparative study of water-cooled versus expandable systems.

Authors:  T de Baere; A Denys; B J Wood; N Lassau; M Kardache; V Vilgrain; Y Menu; A Roche
Journal:  AJR Am J Roentgenol       Date:  2001-01       Impact factor: 3.959

7.  Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model.

Authors:  S B Chinn; F T Lee; G D Kennedy; C Chinn; C D Johnson; T C Winter; T F Warner; D M Mahvi
Journal:  AJR Am J Roentgenol       Date:  2001-03       Impact factor: 3.959

8.  Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies.

Authors:  A S Pearson; F Izzo; R Y Fleming; L M Ellis; P Delrio; M S Roh; J Granchi; S A Curley
Journal:  Am J Surg       Date:  1999-12       Impact factor: 2.565

9.  Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation.

Authors:  S N Goldberg; G S Gazelle; C C Compton; P R Mueller; K K Tanabe
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860

10.  Radiofrequency ablation of unresectable hepatic malignancies: lessons learned.

Authors:  A J Bilchik; T F Wood; D P Allegra
Journal:  Oncologist       Date:  2001
View more
  5 in total

1.  A case of hepatocellular carcinoma treated by radiofrequency ablation confirming the adjacent major bile duct under hybrid contrast mode through a biliary drainage catheter.

Authors:  Yusuke Imai; Masashi Hirooka; Hironori Ochi; Yohei Koizumi; Yoshinori Ohno; Takao Watanabe; Yoshio Tokumoto; Teru Kumagi; Masanori Abe; Yoichi Hiasa
Journal:  Clin J Gastroenterol       Date:  2015-08-29

Review 2.  Efficacy of 125I Versus Non-125I Combined with Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma with Obstructive Jaundice.

Authors:  Shuangxi Li; Xuewen He; Lei Dang; Fangyu Xu; Jin Fang; Fenqiang Li; Wenhui Wang
Journal:  Dig Dis Sci       Date:  2018-01-05       Impact factor: 3.199

3.  Complications of radiofrequency ablation of neoplasms.

Authors:  Albert A Nemcek
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

4.  Risk Factors for Bile Duct Injury After Percutaneous Thermal Ablation of Malignant Liver Tumors: A Retrospective Case-Control Study.

Authors:  Man-Xia Lin; Jie-Yi Ye; Wen-Shuo Tian; Ming Xu; Bo-Wen Zhuang; Ming-De Lu; Xiao-Yan Xie; Ming Kuang
Journal:  Dig Dis Sci       Date:  2017-02-15       Impact factor: 3.199

5.  The efficacy of the combination of percutaneous transhepatic biliary drainage and 125I stranded seeds for malignant bile duct obstruction treatment.

Authors:  Shuangxi Li; Baohua Li; Lei Li; Xujun Yang; Fangyu Xu; Wenhui Wang
Journal:  J Contemp Brachytherapy       Date:  2020-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.